Arcturus Therapeutics Holdings (ARCT) Non-Current Debt (2018 - 2025)

Arcturus Therapeutics Holdings (ARCT) has 7 years of Non-Current Debt data on file, last reported at $15.0 million in Q1 2025.

• Quarterly Non-Current Debt changed N/A year-over-year to $15.0 million in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $15.0 million (changed N/A YoY) and the FY2022 annual result came in at $50.4 million, up 24.04% from the prior year.
• Non-Current Debt fell to $15.0 million in Q1 2025, from $20.0 million in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $58.1 million in Q1 2021 to a low of $15.0 million in Q1 2025.
• A 4-year average of $39.0 million and a median of $39.9 million in 2021 frame the typical range for Non-Current Debt.
• Annual changes were most pronounced in 2021 — Non-Current Debt soared 286.92% — and 2023, when it plunged 37.57%.
• Tracing ARCT's Non-Current Debt over 4 years: stood at $40.6 million in 2021, then increased by 24.04% to $50.4 million in 2022, then tumbled by 60.32% to $20.0 million in 2023, then retreated by 25.0% to $15.0 million in 2025.
• The last three Non-Current Debt figures came in at $15.0 million (Q1 2025), $20.0 million (Q3 2023), and $50.4 million (Q4 2022), per Business Quant data.